Alumis Inc. ALMS Accrued Research And Development Current
Accrued Research And Development Current at other companies
Other financials
Where this comes from
Reported directly by Alumis Inc. in its filing.
Tagged under the XBRL concept alms:AccruedResearchAndDevelopmentCurrent.
The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alumis Inc.'s accrued research and development current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alumis Inc.'s accrued research and development current?
- Alumis Inc. (ALMS) reported accrued research and development current of $35.96M in Q1 2026.
- How has Alumis Inc.'s accrued research and development current changed year-over-year?
- Alumis Inc.'s accrued research and development current increased by 3.6% year-over-year, from $34.7M to $35.96M.
- What is the long-term trend for Alumis Inc.'s accrued research and development current?
- Over 2 years (2023 to 2025), Alumis Inc.'s accrued research and development current has grown at a 78.3% compound annual growth rate (CAGR), from $10.95M to $34.78M.
- What does accrued research and development current mean?
- This represents obligations for research and development services that have been performed by third parties but have not yet been invoiced or paid. It serves as a key indicator of the company's ongoing clinical trial activity and the associated financial liabilities incurred during the development process. Investors use this to gauge the true scale of R&D activity beyond what is reflected in cash payments.